FPHAX Holdings List

As of Feb 28, 2025

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	26.72%	382,961
2	NVO	Novo Nordisk A/S	14.35%	2,088,600
3	AZN	AstraZeneca PLC	10.37%	1,795,200
4	n/a	Fidelity Revere Street Trust - Fidelity Securities Lending Cash Central Fund	5.60%	73,915,009
5	MRK	Merck & Co., Inc.	4.91%	702,736
6	EBR: UCB	UCB SA	4.90%	343,100
7	GSK	GSK plc	4.82%	1,691,260
8	GILD	Gilead Sciences, Inc.	4.72%	544,700
9	RPRX	Royalty Pharma plc	2.81%	1,103,200
10	LEGN	Legend Biotech Corporation	2.30%	866,000
11	n/a	Fidelity Revere Street Trust - Fidelity Cash Central Fund	2.24%	29,565,259
12	ELAN	Elanco Animal Health Incorporated	2.22%	2,625,600
13	SWX: ROG	Roche Holding AG	1.64%	65,000
14	RNA	Avidity Biosciences, Inc.	1.45%	625,900
15	ZTS	Zoetis Inc.	1.13%	89,200
16	PTCT	PTC Therapeutics, Inc.	1.06%	253,000
17	BNTX	BioNTech SE	1.03%	120,153
18	JAZZ	Jazz Pharmaceuticals plc	0.97%	89,200
19	LUNG	Pulmonx Corporation	0.95%	1,459,051
20	XENE	Xenon Pharmaceuticals Inc.	0.85%	301,900
21	RCUS	Arcus Biosciences, Inc.	0.81%	986,517
22	ETR: MRK	Merck KGaA	0.67%	62,700
23	MRNA	Moderna, Inc.	0.61%	261,200
24	IRON	Disc Medicine, Inc.	0.61%	142,500
25	AXSM	Axsome Therapeutics, Inc.	0.57%	59,200
26	n/a	METSERA INC 180-DAY LOCK-UP LINE 07/30/2025	0.52%	278,676
27	DYN	Dyne Therapeutics, Inc.	0.50%	485,400
28	EBR: IBAB	Ion Beam Applications SA	0.43%	422,400
29	ASND	Ascendis Pharma A/S	0.43%	36,100
30	MRUS	Merus N.V.	0.42%	117,400
31	SMMT	Summit Therapeutics Inc.	0.41%	264,317
32	QURE	uniQure N.V.	0.40%	405,300
33	SRPT	Sarepta Therapeutics, Inc.	0.40%	49,300
34	HRMY	Harmony Biosciences Holdings, Inc.	0.34%	130,677
35	CRNX	Crinetics Pharmaceuticals, Inc.	0.33%	122,800
36	BEAM	Beam Therapeutics Inc.	0.30%	148,200
37	OCUL	Ocular Therapeutix, Inc.	0.23%	427,500
38	AVBP	ArriVent BioPharma, Inc.	0.23%	128,700
39	EBR: NYXH	Nyxoah SA	0.23%	298,200
40	VIR	Vir Biotechnology, Inc.	0.18%	280,800
41	EBR: NYXH	Nyxoah SA	0.17%	221,500
42	EWTX	Edgewise Therapeutics, Inc.	0.17%	83,600
43	SYRE	Spyre Therapeutics, Inc.	0.16%	106,942
44	n/a	PARAGON BIOSCIENCES EMALEX CAPITAL INC SER C PC PP	0.15%	158,879
45	n/a	AGOMAB THERAPEUTICS SA SER D PC PP	0.14%	7,649
46	VKTX	Viking Therapeutics, Inc.	0.14%	65,000
47	n/a	AGOMAB THERAPEUTICS SA SER C PC PP	0.14%	7,729
48	NTLA	Intellia Therapeutics, Inc.	0.13%	172,900
49	n/a	CASTLE CREEK BIOSCIENCES INC SER D-1 PC PP	0.11%	6,308
50	PRTA	Prothena Corporation plc	0.09%	75,800

As of Feb 28, 2025

Showing 50 of 65

Subscribe to see the full list

Asset Allocation

Asset Class	% Weight
Stocks	96.36%
Cash	2.38%
Other	1.18%
Bond	0.08%

Sector Breakdown

Sector	% Weight
Health Care	73.07%
Other	26.93%

Country Breakdown

Sector	% Weight
United States	82.63%
Switzerland	5.69%
Germany	3.76%
Belgium	2.57%
Netherlands	1.27%
Ireland	0.92%
Sweden	0.90%
France	0.90%
Denmark	0.68%
Other	0.68%